课题基金 / 基金详情

The pathological investigation of proliferative diabetic retinopathy based on the control of retinal pericytes

The pathological investigation of proliferative diabetic retinopathy based on the control of retinal pericytes
基于视网膜周细胞控制的增殖性糖尿病视网膜病变的病理学研究
批准号:
12470363
负责人:
TAKAGI Hitoshi
金额:
$9.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

TAKAGI Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
本研究旨在探讨视网膜内皮细胞和周细胞的调控机制,为眼内血管增生性疾病的治疗提供新的思路。在糖尿病视网膜病变中,已知周细胞损失会引起微动脉瘤和血管通透性过高。在链脲佐菌素诱导的糖尿病大鼠中,通过RT-PCR分析证明血管生成素2在糖尿病发作6个月后高度表达,并且通过原位杂交和双重免疫染色分析观察到血管生成素2表达的视网膜部位的周细胞损失。(IOVS 2003;44;393-402)。在糖尿病视网膜病变的眼睛中,血管紧张素2选择性地增强视网膜内皮细胞中的血管生成素2,这表明血管紧张素2在内皮细胞和周细胞之间的关系中的作用。(Diabetes 2001;50;867-875)。这些结果被高度评价为临床试验的基础数据,如DIRECT研究。接下来,我们的目标是在周细胞变性的血管中进行新的治疗开发。将针对PDGFR-β的拮抗性mAb注射到鼠新生儿中提供了视网膜血管的这样的周细胞损失,并且这样的小鼠的血管重塑不良并且渗漏。该模型类似于糖尿病视网膜病变的病理变化。我们发现,除了重组修饰的血管生成素1恢复了分级valculature,也挽救了视网膜水肿和出血的完全缺席的周细胞。这些观察结果表明血管生成素1作为糖尿病视网膜病变等疾病中周细胞损失的新治疗方式的潜力。(JCI 2002;110;1619-28)。血管生成素1和血管紧张素1型受体阻滞剂可能是治疗糖尿病视网膜病变的有效药物。
英文摘要
In this research, we investigated the control mechanism of retinal endothelial cells and pericytes, and aimed at a new therapeutic development of intraocular vascular proliferative diseases. In a diabetic retinopathy, pericyte loss is known to cause microaneuiysms and vascular hyperpermiability. In streptozotocine-induced diabetic rats, angiopoietine 2 is proved to be highly expressed after 6 months from onset of diabetes by RT-PCR analyses, and pericyte loss is observed by in situ hybridization and double immune staining analyses in the retinal cite where angiopoietine 2 is expressed. (IOVS 2003;44;393-402). In the eyes of diabetic retinopathy, angiotensin 2 selectively potentiates angiopoietine 2 in retinal endothelial cells, and this suggests the role of angiotensin 2 in the relation between endothelial cells and pericytes. (Diabetes 2001;50;867-875). These results are highly evaluated as a basic data on clinical trials, such as DIRECT study. In the next, we aimed a new therapeutic development on such vessels in which pericytes are degenerated. The injection of an antagonistic mAb against PDGFR-beta into murine neonates provides such pericyte loss of retinal vessels, and vessels of such mice are poorly remodeled and leaky. This model resembles a pathological change in diabetic retinopathy. We show that addition of recombinant modified angiopoietin 1 restored a hierarchical valculature, and also rescued retinal edema and hemorrhage in the complete absensce of pericytes. These observations demonstrate the potential of angiopoietin 1 as a new therapeutic modality for pericyte loss in diseases such as diabetic retinopathies. (JCI 2002;110;1619-28). Angiopoietin 1 and angiotensin type 1 receptor blocker are possible to be an effective drug in a diabetic retinopathy.
期刊论文(60)
专著(0)
科研奖励(0)
会议论文
Otani A, Takagi H, Oh H, Koyama S, Ogura Y, Matsumura M, Honda Y: "Vascular Endothelial Growth Factor Family and Receptor Expression in Human Choroidal Neovascular Membranes"Microvascular Res.. (in press).
Otani A、Takagi H、Oh H、Koyama S、Ogura Y、Matsumura M、Honda Y:“血管内皮生长因子家族和人脉络膜新生血管膜中的受体表达”微血管研究(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
王英泰: "Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells."J Biol Chem. 28. 15732-15739 (1999)
王英泰:“缺氧和血管内皮生长因子选择性上调牛微血管内皮细胞中的血管生成素-2。”J Biol Chem. 28. 15732-15739 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
鈴間潔: "Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization"Microvasc.Res. 56. 183-191 (1998)
Kiyoshi Suzuma:“缺血诱导的视网膜新生血管的小鼠模型中 KDR/Flk-1 (VEGFR-2) 的表达增加”Microvasc.Res. 56. 183-191 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Otani A, et al.: "Angiotensin-II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells"Diabetes. 50. 867-875 (2001)
Otani A 等人:“血管紧张素-II 诱导牛视网膜内皮细胞中 Tie2 受体配体血管生成素-2 的表达”糖尿病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 30 条
    Development of low-cost extraction method for cellulose nanofiber from paper sludge and application to biocomposites
    • 批准号:
      24656394
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2012
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    Clinical evidence-based investigation of developmental mechanism in diabetic retinopathy
    • 批准号:
      23592594
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2011
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    Development of nano cellulose fiber green composites fabricated by combining controlled solidification and freeze-drying
    • 批准号:
      20560642
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2008
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    Combination therapy of apoptosis induction and molecular targeting for hepatocellular carcinoma. -Transgenic mice study-
    • 批准号:
      15590619
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2003
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    国内基金
    海外基金
    阴茎血管外周细胞(Pericytes)介导的阴茎血管再生机制的研究及以其开发勃起功能障碍的治疗新靶点
    • 批准号:
      81871156
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2018
    • 负责人:
      金海荣
    • 依托单位: